FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.
Saved in:
| Title: | FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. |
|---|---|
| Authors: | Mostafa A; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Kandeil A; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., A M M Elshaier Y; Organic & Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City, Menoufia 32897, Egypt., Kutkat O; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Moatasim Y; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Rashad AA; Department of Biochemistry & Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102, USA., Shehata M; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Gomaa MR; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Mahrous N; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Mahmoud SH; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., GabAllah M; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Abbas H; Department of Microbiology and Immunology, Zagazig University, Zagazig 44519, Egypt., Taweel AE; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Kayed AE; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Kamel MN; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Sayes ME; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Mahmoud DB; Pharmaceutics Department, National Organization for Drug Control and Research, Giza 12654, Egypt., El-Shesheny R; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Kayali G; Department of Epidemiology, Human Genetics, and Environmental Sciences, University of Texas, Houston, TX 77030, USA.; Human Link, Baabda 1109, Lebanon., Ali MA; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt. |
| Source: | Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2020 Dec 04; Vol. 13 (12). Date of Electronic Publication: 2020 Dec 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33291642 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mostafa+A%22">Mostafa A</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Kandeil+A%22">Kandeil A</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22A+M+M+Elshaier+Y%22">A M M Elshaier Y</searchLink>; Organic & Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City, Menoufia 32897, Egypt.<br /><searchLink fieldCode="AU" term="%22Kutkat+O%22">Kutkat O</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Moatasim+Y%22">Moatasim Y</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Rashad+AA%22">Rashad AA</searchLink>; Department of Biochemistry & Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.<br /><searchLink fieldCode="AU" term="%22Shehata+M%22">Shehata M</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Gomaa+MR%22">Gomaa MR</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Mahrous+N%22">Mahrous N</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Mahmoud+SH%22">Mahmoud SH</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22GabAllah+M%22">GabAllah M</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Abbas+H%22">Abbas H</searchLink>; Department of Microbiology and Immunology, Zagazig University, Zagazig 44519, Egypt.<br /><searchLink fieldCode="AU" term="%22Taweel+AE%22">Taweel AE</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Kayed+AE%22">Kayed AE</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Kamel+MN%22">Kamel MN</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Sayes+ME%22">Sayes ME</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Mahmoud+DB%22">Mahmoud DB</searchLink>; Pharmaceutics Department, National Organization for Drug Control and Research, Giza 12654, Egypt.<br /><searchLink fieldCode="AU" term="%22El-Shesheny+R%22">El-Shesheny R</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.<br /><searchLink fieldCode="AU" term="%22Kayali+G%22">Kayali G</searchLink>; Department of Epidemiology, Human Genetics, and Environmental Sciences, University of Texas, Houston, TX 77030, USA.; Human Link, Baabda 1109, Lebanon.<br /><searchLink fieldCode="AU" term="%22Ali+MA%22">Ali MA</searchLink>; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238453%22">Pharmaceuticals (Basel, Switzerland)</searchLink> [Pharmaceuticals (Basel)] 2020 Dec 04; Vol. 13 (12). <i>Date of Electronic Publication: </i>2020 Dec 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101238453 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1424-8247 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214248247%22">14248247 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceuticals (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33291642 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/ph13120443 Languages: – Code: eng Text: English Titles: – TitleFull: FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mostafa A – PersonEntity: Name: NameFull: Kandeil A – PersonEntity: Name: NameFull: A M M Elshaier Y – PersonEntity: Name: NameFull: Kutkat O – PersonEntity: Name: NameFull: Moatasim Y – PersonEntity: Name: NameFull: Rashad AA – PersonEntity: Name: NameFull: Shehata M – PersonEntity: Name: NameFull: Gomaa MR – PersonEntity: Name: NameFull: Mahrous N – PersonEntity: Name: NameFull: Mahmoud SH – PersonEntity: Name: NameFull: GabAllah M – PersonEntity: Name: NameFull: Abbas H – PersonEntity: Name: NameFull: Taweel AE – PersonEntity: Name: NameFull: Kayed AE – PersonEntity: Name: NameFull: Kamel MN – PersonEntity: Name: NameFull: Sayes ME – PersonEntity: Name: NameFull: Mahmoud DB – PersonEntity: Name: NameFull: El-Shesheny R – PersonEntity: Name: NameFull: Kayali G – PersonEntity: Name: NameFull: Ali MA IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 12 Text: 2020 Dec 04 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 1424-8247 Numbering: – Type: volume Value: 13 – Type: issue Value: 12 Titles: – TitleFull: Pharmaceuticals (Basel, Switzerland) Type: main |
| ResultId | 1 |